P555 Outcomes of multiswitching from original infliximab to biosimilars in patients with inflammatory bowel disease
2021
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI